Description
Get Access to elexacaftor, tezacaftor and ivacaftor for Tablets in India
Trikafta is a combination of ivacaftor, a CFTR potentiator, tezacaftor, and elexacaftor used for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one F508del mutation in the CFTR gene or a mutation in the CFTR gene that is responsive.
Recommended Dosage: The recommended morning and the evening dose should be taken orally approximately 12 hours apart. Swallow tablets whole. The trikafta tablets should be taken with fat-containing food. Examples of snacks or meals that contain fat are those prepared with oils, or butter or those containing cheeses, eggs, nuts, whole milk, or meats.
FAQ's
Is Trikafta available in India?
Yes, Trikafta is available in India on request. To get the access brand name for Trikafta in India, kindly contact Lucknow Speciality Pharma at M: 9336559090.
How much does Trikafta cost in India?
The cost of Trikafta India can vary. To procure this medication legally, you can call at +91 9336559090 or WhatsApp at 9336559090 or email us at info@lucknowpharma.com
We are the supplier of “Trikafta ” to following cities in India-
Lucknow Speciality Pharma has delivered “Trikafta “ in Kanpur, Lucknow, Ghaziabad, Agra, Meerut, Varanasi, Prayagraj, Bareilly, Aligarh, Moradabad, Saharanpur, Gorakhpur, Noida, Firozabad, Jhansi, Muzaffarnagar, Mathura-Vrindavan, Ayodhya, Rampur, Shahjahanpur, Farrukhabad-Fatehgarh, Budaun, Maunath, Hapur, Etawah, Mirzapur-Vindhyachal, Bulandshahr, Sambhal, Amroha, Hardoi, Fatehpur, Raebareli, Orai, Sitapur, Bahraich, Modinagar, Unnao, Jaunpur, Lakhimpur, Hathras, Banda, Pilibhit, Barabanki, Khurja, Gonda, Mainpuri, Lalitpur, Etah, Deoria, Badaun, Ghazipur, Sultanpur, Azamgarh, Bijnor, Sahaswan, Basti, Chandausi, Akbarpur, Ballia, Ambedkar Nagar, Greater Noida, Shikohabad, Patna, Gaya, Bhagalpur, Muzaffarpur, Darbhanga, Siwan, Sasaram, Hajipur, Burdwan, Kolkata, Kharagpur, Asansol, Haldia, Siliguri, Howrah, Imphal, Guwahati and Agartala, Indore, Bhopal and Nepal.